Vildagliptin reversed diabetes-induced decrease of p-Akt, p-GSK-3β, brain-derived neurotrophic factor and nerve growth factor, thus against cognitive deficits and memory impairment [20]. The gene discussed is GSK3B; the disease is memory impairment.